Table 1 A summary of the data in Table 1, by continent and an overall global estimate of COPD prevalence, hospitalisation rate, IA prevalence in COPD and associated mortality
Region | Population size [16] | COPD population GOLD stages II-IV | COPD annual hospitalisation rate [18] | IA annual incidence per 100,000 population | ||||
|---|---|---|---|---|---|---|---|---|
n (% of population) | 10.5% of COPD population | 1.30–3.90% of COPD hospitalisation rate | n (% of IA cases) | |||||
Africa | 1,197,415,000 | 64,298,051 (5.37) | 6,751,295 | 87,767 | 1.3% | 62,929 | 71.7% | 7.3 |
271,877 | 3.9% | 115,996 | 43.0% | 22.7 | ||||
America | 1,001,386,000 | 85,278,783 (8.52) | 8,954,272 | 116,406 | 1.3% | 83,463 | 71.7% | 11.6 |
349,217 | 3.9% | 150,163 | 43.0% | 34.9 | ||||
Asia | 4,476,519,000 | 339,206,893 (8.58) | 35,616,724 | 462,894 | 1.3% | 331,895 | 71.7% | 10.3 |
1,389,052 | 3.9% | 597,292 | 43.0% | 31.0 | ||||
Europe | 765,958,000 | 59,484,329 (7.77) | 6,245,855 | 81,196 | 1.3% | 58,218 | 71.7% | 10.6 |
247,744 | 3.9% | 106,530 | 43.0% | 32.3 | ||||
Oceania | 37,131,000 | 4,032,543 (10.86) | 423,417 | 5504 | 1.3% | 3947 | 71.7% | 14.8 |
16,513 | 3.9% | 7101 | 43.0% | 44.5 | ||||
Globally | 7,478,409,000 | 552,300,599 (7.39) | 57,991,563 | 753,073 | 1.3% | 540,451 | 71.7% | 10.0 |
2,272,322 | 3.9% | 977,082 | 43.0% | 30.40 | ||||